Upadacitinib versus Placebo or Adalimumab in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase 3, Double-Blind, Randomized Controlled Trial
Arthritis Rheumatol 2019 DOI: 10.1002/art.41032
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Rheumatol 2019 DOI: 10.1002/art.41032
Arthritis Rheumatol. 2019 Jun;71(6):878-891
Please click the links below to go to the CSF review of each paper
Clinical Rheumatology 2018;37:2381–90 DOI 10.1007/s10067-018-4221-0
Rheumatology 2018;57:1423–1431 DOI: 10.1093/rheumatology/key121
RMD Open. 2018 May 8;4(1):e000662. DOI: 10.1136/rmdopen-2018-000662
Rheumatol Ther. 2018 Dec;5(2):341-353. doi: 10.1007/s40744-018-0113-7
Clin Rheumatol 2018 Aug; 37(8):2043–53
Rheumatology (Oxford) 2018; 57(2):309–17
Please click the links below to go to the CSF review of each paper.